The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
VEGF Gene Delivery to Myocardium: Deleterious Effects of Unregulated Expression
Abstract
Background —Vascular endothelial growth factor (VEGF) is being investigated for therapeutic angiogenesis in ischemic myocardium. Primarily, transient delivery systems have been tested. The goal of this study was to investigate the effects of continuous expression of VEGF in myocardium by use of myoblast-mediated delivery. Methods and Results —Primary murine myoblasts (5×10 5 cells in 10 μL of PBS with 0.5% BSA) expressing both the murine VEGF gene and the β-galactosidase (β-gal) gene from a retroviral promoter were implanted in the ventricular wall of immunodeficient mice (n=11) via a subdiaphragmatic approach. Control immunodeficient mice (n=12) were injected with the same number of myoblasts expressing only the β-gal gene. Between days 14 and 16, surviving mice were euthanized and the hearts processed for histology. In the experimental group, 11 of 11 mice demonstrated failure to thrive by day 13; 5 deaths occurred between days 8 and 15. There were no complications in the control mice. Histochemistry documented successful implantation of myoblasts (positive β-gal reaction product) in 6 of 6 surviving experimental mice and 12 of 12 controls. Histology disclosed intramural vascular tumors resembling hemangiomas in the VEGF-myoblast–injected myocardium in 6 of 6 surviving mice. β-Gal–expressing cells were present at the site of the vascular tumors. Immunohistochemistry localized abundant endothelial nitric oxide synthase and CD31 (platelet and endothelial cell adhesion molecule) within the lesion, consistent with the presence of endothelial cells. Conclusions —In this model, unregulated continuous expression of VEGF is associated with (1) a high rate of failure to thrive/death and (2) formation of endothelial cell–derived intramural vascular tumors in the implantation site. These results underscore the importance of regulating VEGF expression for therapeutic angiogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isner, J. M., Pieczek, A., Schainfeld, R., Blair, R., Haley, L., Asahara, T., Rosenfield, K., Razvi, S., Walsh, K., & Symes, J. F. (1996) · The Lancet · doi:10.1016/s0140-6736(96)03361-2 · Cited by 989
Losordo, D. W., Vale, P. R., Symes, J. F., Dunnington, C. H., Esakof, D. D., Maysky, M., Ashare, A. B., Lathi, K., & Isner, J. M. (1998) · Circulation · doi:10.1161/01.cir.98.25.2800 · Cited by 987
Rando, T. A., & Blau, H. M. (1994) · The Journal of cell biology · doi:10.1083/jcb.125.6.1275 · Cited by 936
Self-citationRosengart, T. K., Lee, L. Y., Patel, S. R., Sanborn, T. A., Parikh, M., Bergman, G. W., Hachamovitch, R., Szulc, M., Kligfield, P. D., Okin, P. M., et al. (1999) · Circulation · doi:10.1161/01.cir.100.5.468 · Cited by 656
Skeletal myoblast transplantation for repair of myocardial necrosis.
Murry, C. E., Wiseman, R. W., Schwartz, S. M., & Hauschka, S. D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119070 · Cited by 615
Banai, S., Jaklitsch, M. T., Shou, M., Lazarous, D. F., Scheinowitz, M., Biro, S., Epstein, S. E., & Unger, E. F. (1994) · Circulation · doi:10.1161/01.cir.89.5.2183 · Cited by 596
Reinecke, H., Zhang, M., Bartosek, T., & Murry, C. E. (1999) · Circulation · doi:10.1161/01.cir.100.2.193 · Cited by 515
Tsurumi, Y., Takeshita, S., Chen, D., Kearney, M., Rossow, S. T., Passeri, J., Horowitz, J. R., Symes, J. F., & Isner, J. M. (1996) · Circulation · doi:10.1161/01.cir.94.12.3281 · Cited by 389
Springer, M. L., Chen, A. S., Kraft, P. E., Bednarski, M., & Blau, H. M. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80154-9 · Cited by 363
Self-citationTremblay, J. P., Malouin, F., Roy, R., Huard, J., Bouchard, J. P., Satoh, A., & Richards, C. L. (1993) · Cell Transplantation · doi:10.1177/096368979300200203 · Cited by 345
Cited by
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00228-4 · Cited by 3,361
The FGF family: biology, pathophysiology and therapy
Beenken, A., & Mohammadi, M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2792 · Cited by 1,945
Ruhrberg, C., Gerhardt, H., Golding, M., Watson, R., Ioannidou, S., Fujisawa, H., Betsholtz, C., & Shima, D. T. (2002) · Genes & Development · doi:10.1101/gad.242002 · Cited by 914
Pathophysiological consequences of VEGF-induced vascular permeability
Weis, S. M., & Cheresh, D. A. (2005) · Nature · doi:10.1038/nature03987 · Cited by 909
Peng, H., Wright, V., Usas, A., Gearhart, B., Shen, H.-C., Cummins, J., & Huard, J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15153 · Cited by 733
Metadata
- Authors
- Lee, R. J., Springer, M. L., Blanco-Bose, W. E., Shaw, R., Ursell, P. C., & Blau, H. M.
- Venue
- Circulation
- Published
- 2000-08-22
- Volume
- 102
- Issue
- 8
- Pages
- 898-901
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2119841264
- Cited by
- 697
- References
- 27
- FWCI
- 14.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: VEGF Gene Delivery to Myocardium: Deleterious Effects of Unregulated Expression. https://app.cochat.ai/papers/10.1161/01.cir.102.8.898
- The paper
- Lee, R. J., Springer, M. L., Blanco-Bose, W. E., Shaw, R., Ursell, P. C., & Blau, H. M. (2000). VEGF Gene Delivery to Myocardium: Deleterious Effects of Unregulated Expression. Circulation. https://doi.org/10.1161/01.cir.102.8.898
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
